Newlink Genetics reported $-7488000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Bristol Myers Squibb BMY:US $ 5289M 67M
Capricor Therapeutics CAPR:US $ -3.93M 0.82M
Celldex Therapeutics CLDX:US $ -20.68M 7.31M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Idera Pharmaceuticals IDRA:US $ -5.96M 0.41M
Intrexon XON:US $ -29.88M 9.76M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Newlink Genetics NLNK:US $ -7.49M 1.18M
Prothena PRTA:US $ 109.2M 81.3M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Vascular Biogenics VBLT:US -6502000 1.53M